The project, funded through the European Commission’s 6th Framework Programme, sets the stage for an open-access resource of binding molecules directed against the entire human proteome, the full set of over 100,000 proteins specified by the human genome.
Established with initial funding of €1.8 M over 4 years, ‘ProteomeBinders’ is co-ordinated by Dr Mike Taussig, Head of the Technology Research Group at the Babraham Institute, and brings together 26 European partners from 12 countries, and two from the USA.
A major challenge of the post-genomic era is to understand how the information encoded within the genome, and expressed as the proteome, choreographs the biological organisation of cells, tissues and organisms. “This requires a comprehensive, standardised collection of specific protein-binding molecules. ‘ProteomeBinders’ aims to provide the tools required to detect and characterise all the relevant human proteins in tissues and fluids in health and disease,” commented Mike Taussig. Currently, antibodies are the most widely used protein-binders, but novel binder types based on alternative protein scaffolds, nucleic acids, peptides and chemical entities each have significant advantages and will be evaluated through this collaboration.
Currently there is no pan-European platform for the systematic development and quality control for these essential reagents. The ‘ProteomeBinders’ consortium will coordinate a new European resource, by integrating existing infrastructures, reviewing technologies and high-throughput production methods, standardising tools and applications, and establishing a database.
As one of the largest genome-scale projects in Europe, aiming ultimately to produce and collect hundreds of thousands of specific binders, this resource brings benefits to basic and applied research. The resource will impact on healthcare, diagnostics, target discovery for drug intervention and therapeutics, and will consequently deliver advantages to the research, medical and biotechnology communities.Contact details:
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences